Anthraquinones from the Endophytic Streptomyces griseoincarnatus SB03 (Ocimum basilicum): Isolation and Evaluation of Antibacterial and Cytotoxic Activities
Pakistan Journal of Biological Sciences · 2025
DOI: 10.3923/pjbs.2025.587.600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Biological Sciences, 2025. Verfasst von Thongchai Taechowisan und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Anthraquinones, Anti-Bacterial Agents, Streptomyces, Ocimum basilicum. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background and Objective: The rising global challenge of drug resistance and cancer demands the discovery of novel therapeutic agents. Endophytic microorganisms, particularly those from medicinal plants like Ocimum basilicum , represent a promising, yet underexplored, source of natural products. This study aimed to isolate and screen bioactive endophytic actinomycetes from O. basilicum roots. The research focused on characterizing the most active isolate, purifying its secondary metabolites and evaluating their antibacterial and anticancer properties. Materials and Methods: The potent strain SB03 was isolated from basil roots and identified as Streptomyces griseoincarnatus using 16S rDNA sequencing. Two compounds were purified from its crude extract and structurally characterized by spectroscopy. Their bioactivities were assessed by determining MIC/MBC against pathogenic bacteria (including MRSA) and IC 50 against human cancer cells (HeLa, HepG2 and MDA-MB-231). Molecular docking investigated their interaction with topoisomerase II, complemented by in silico ADMET analysis.
Results
A potent actinomycete strain, S. griseoincarnatus SB03, was successfully isolated from sweet basil roots. Two known anthraquinone compounds, 2-butyryl-1,8-dihydroxy-3-methyl-anthraquinone (Compound 1 ) and 2-butyryl-1,4,8-trihydroxy-3-methyl-anthraquinone (Compound 2 ), were isolated from the culture extract. Both exhibited strong antibacterial activity (MIC 64-128 μg/mL against Gram-positive strains) and significant cytotoxicity (IC 50 35.01-97.68 μg/mL) against all tested cancer lines. Importantly, they showed a higher selectivity index against the HepG2 line than the control, doxorubicin. Docking studies indicated favorable binding to topoisomerase II.
Conclusion
Streptomyces griseoincarnatus SB03 from sweet basil is a promising source of therapeutic agents. Its anthraquinone metabolites possess valuable dual antibacterial and selective anticancer properties. These compounds are excellent lead candidates for future drug development against infectious diseases and hepatocellular carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Taechowisan, T., Komsuwan, J., Chuen-Im, T., & Phutdhawong, W. S. (2025). Anthraquinones from the Endophytic Streptomyces griseoincarnatus SB03 (Ocimum basilicum): Isolation and Evaluation of Antibacterial and Cytotoxic Activities. Pakistan Journal of Biological Sciences. https://doi.org/10.3923/pjbs.2025.587.600
Vancouver
Taechowisan T, Komsuwan J, Chuen-Im T, Phutdhawong WS. Anthraquinones from the Endophytic Streptomyces griseoincarnatus SB03 (Ocimum basilicum): Isolation and Evaluation of Antibacterial and Cytotoxic Activities. Pakistan Journal of Biological Sciences. 2025. doi:10.3923/pjbs.2025.587.600
BibTeX
@article{Taechowisan2025,
author = {Taechowisan, Thongchai and Komsuwan, Jiraphatch and Chuen-Im, Thanaporn and Phutdhawong, Waya S},
title = {Anthraquinones from the Endophytic Streptomyces griseoincarnatus SB03 (Ocimum basilicum): Isolation and Evaluation of Antibacterial and Cytotoxic Activities},
journal = {Pakistan Journal of Biological Sciences},
year = {2025},
doi = {10.3923/pjbs.2025.587.600}
}
EUVIMED